Aligned or misaligned: Are public funding models for speech-language pathology reflecting recommended evidence? An exploratory survey of Australian speech-language pathologists

• Published in: Health Policy OPEN Vol. 6; p. 100117
• Main Authors: Nickless, T., Davidson, B., Finch, S., Gold, L., Dowell, R.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.12.2024; Elsevier
• Subjects: Full Length; Public funding models; Quantitative research; Speech-language pathology; Quantitative research; Public funding models; Speech-language pathology
• ISSN: 2590-2296; 2590-2296
• DOI: 10.1016/j.hpopen.2024.100117

•Public funding models assist families in accessing critical primary care allied health services such as speech-language pathology.•Policy architects designing healthcare funding must ensure that public funding models are congruent with best-available scientific evidence.•More research is needed on public funding models within private-practice settings and their role in boarder healthcare systems. Government subsidised funding arrangements serve as an essential medium for families to access private speech-language pathology (SLP) services in Australia. This study aimed to investigate whether, from a provider perspective, contemporary public funding models (PFMs) align with best-available scientific evidence for management of children and young persons with swallowing and communication disorders within Australian private-practice settings. This exploratory study was distributed to paediatric speech-language pathologists throughout Australia via an online survey. A total of 121 valid surveys were completed by Australian speech-language pathologists with divergent career experiences. In comparing three familiar PFMs using mixed effects logistic regression models to estimate odds ratios, results indicated that perceived congruence with recommended scientific evidence for SLP management varied across PFMs: the odds of failing to align with scientific evidence was 4.92 times higher for Medicare’s Chronic Disease Management Plan (MBS_CDMP) than for the National Disability Insurance Scheme; and 7.40 times higher in comparison to Medicare’s Helping Children with Autism initiative. This study is the first to report on (in)congruence between PFMs that provide access to independent Australian SLP services for children and young persons and best available scientific evidence to inform clinical practice. Participants identified that: (a) four out of seven contemporary PFMs were unfamiliar to speech-language pathologists; and (b) MBS_CDMP initiative failed to align with the evidence-base for best scientific SLP management.